Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for medicinal cannabis; CDA Clinics, which provides medicinal cannabis consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and plant-based medications, such as medium chain triglyceride oil and whole flower products under the Adaya brand name. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorporated in 2018 and is based in South Yarra, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.057362779560174215 | N/A |
Market Cap | $31.85M | N/A |
Shares Outstanding | 555.20M | 15.08% |
Employees | 0 | N/A |
Shareholder Equity | 34.90M | 33.85% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 2.37 | N/A |
P/S Ratio | 0.41 | N/A |
P/B Ratio | 0.91 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.2628 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $78.27M | N/A |
Earnings | $9.17M | N/A |
EPS | 0.0242 | N/A |
Earnings Yield | 0.4219 | N/A |
Gross Margin | 0.3455 | N/A |
Operating Margin | 0.1693 | N/A |
Net income margin | 0.1172 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $31.28M | N/A |
Total Debt | $853.03K | N/A |
Cash on Hand | $12.57M | N/A |
Debt to Equity | 0.2292 | -46.63% |
Cash to Debt | $14.74 | 363.84% |
Current Ratio | $3.31 | 46.14% |